| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 01/27/2005 | US20050019954 Photochromic dyes for microsphere based sensor |
| 01/27/2005 | US20050019953 Biosensing apparatus for monitoring concentrations of preferential compounds in biological fluids |
| 01/27/2005 | US20050019945 Biosensing apparatus for monitoring concentrations of preferential compounds in biological fluids; blood glucose sensor |
| 01/27/2005 | US20050019944 Colorable microspheres for DNA and protein microarray |
| 01/27/2005 | US20050019943 Automatic blood analysis and identification system |
| 01/27/2005 | US20050019940 Assay for monitoring physical, chemical and performance property of a reaction product; analysis of combinatorial library |
| 01/27/2005 | US20050019939 Combination marker for liquids and method identification thereof |
| 01/27/2005 | US20050019937 Assay and kit for homocysteine |
| 01/27/2005 | US20050019936 Spectroscopic method and apparatus for total hemoglobin measurement |
| 01/27/2005 | US20050019921 Method for combined sequential agent delivery and electroporation for cell structures and use thereof |
| 01/27/2005 | US20050019900 Using capacitance variation to determine concentration of liquids in a reaction chamber; high throughput assay; detecting microorganisms in culture population |
| 01/27/2005 | US20050019898 Fluid mixing in low aspect ratio chambers |
| 01/27/2005 | US20050019892 Screening process for antibacterial agents |
| 01/27/2005 | US20050019889 Human osteoclast derived cathepsin |
| 01/27/2005 | US20050019884 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 01/27/2005 | US20050019872 PC-LECTIN protein; vaccines and diagnostic marker for prostate cancer |
| 01/27/2005 | US20050019870 Monoclonal antibody specific to tuumor associated prostate gene for use diagnostic tool in detection and classification of cell proliferative disorders |
| 01/27/2005 | US20050019866 Nucleotide sequences coding membrane protein for use in diagnosis, detection, prevention and/or treatment of cell proliferative disorders |
| 01/27/2005 | US20050019854 Analyzing insulin response; solid phase synthesis; for treatment of prediabetes, hyperinsulinemia, and type II diabetes; kits |
| 01/27/2005 | US20050019851 Use of VLCFAE for identifying herbicidally active compounds |
| 01/27/2005 | US20050019849 Such as glucose oxidase, cholesterol oxidase, lactate oxidase, and/or sarcosine oxidase; luminescent dyes as transducers |
| 01/27/2005 | US20050019847 Using preferential antibodies to identify ubiquitin-like protein (ISG15); immunodiagnostics; wound healing agents |
| 01/27/2005 | US20050019846 Using ornithine carbamoyltransferase (OCT) as diagnostic tool in screening for antifungal agents; fungicides and disease resistant plants |
| 01/27/2005 | US20050019845 Immunoconjugates of antibodies and cytotoxic agents (ricin, taxol); for treament of cancer and metastasis; tomography |
| 01/27/2005 | US20050019844 Labelling with 4-chloro-7-nitrobenzofurazan or 4-fluoro-7-nitrobenzofurazan dyes; solid phase synthesis; kits |
| 01/27/2005 | US20050019843 Profiling lymphocyte populaations using microarry comprised of discrete domains of major histocompatibility complex for use in monitoring infection, rejection of cancer cells and autoimmune responses |
| 01/27/2005 | US20050019842 Analyzing the identification and the concentration of particular target analytes; biological and chemical assays, receptor binding assay; bioassay of proteins, nucleic acids, peptide nucleic acids, biological cells, microorganisms |
| 01/27/2005 | US20050019841 Modulation of signaling pathways |
| 01/27/2005 | US20050019840 Non-endogenous, constitutively activated known G protein-coupled receptors |
| 01/27/2005 | US20050019839 Secretions of proteins by encapsulated cells |
| 01/27/2005 | US20050019837 Using glutamate decarboxylase concentration as diagnostic indicator of autoimmune and connective tissue disorders |
| 01/27/2005 | US20050019836 Bioanalytical reagent, method for production thereof, sensor platforms and detection methods based on use of said bioanalytical reagent |
| 01/27/2005 | US20050019835 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor |
| 01/27/2005 | US20050019832 IGF-1 receptor interacting proteins |
| 01/27/2005 | US20050019831 Facilitated forward chemical genetics using tagged triazine library |
| 01/27/2005 | US20050019830 Methods of screening for TRPM5 modulators |
| 01/27/2005 | US20050019829 Generating and identifying polypeptide stability, folding and/or solubility mutants comprising; mutagenizing gene sequences, expressing in hosst cell, determine protein structure |
| 01/27/2005 | US20050019823 Using enhanced concentration of transmembrane polypeptide as diagnostic indicator of cell proliferative disorers; diagnosing cancer; antitumor agents |
| 01/27/2005 | US20050019822 Using presence of short tandem repeat sequence in promoter region of cholecystokinin gene as a diagnostic indicator of panic associated psychological/psychiatric disorders; anxiolytic agents |
| 01/27/2005 | US20050019821 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/27/2005 | US20050019817 Producing oligonucleotides extended by a single nucleotide base; comprising preparing single stranded nucleotide mixture, incubate with terminal transferase and labeled chain terminating agents, recovvering reaction product; generating oligonucleotide standards |
| 01/27/2005 | US20050019812 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019811 Neutral amino acid transporter and gene thereof |
| 01/27/2005 | US20050019810 Nucleotide sequences coding transmembrane protein (TANGO) for use as tool in detection of modulator for prevention and treatment of inflammation and cell proliferative disorders |
| 01/27/2005 | US20050019807 Using labeled amino acids to monitor in vitro translation products; parallel analysis of a plurality of protein expression levels |
| 01/27/2005 | US20050019806 Nucleic acids and polypeptides required for cell survival in the absence of Rb |
| 01/27/2005 | US20050019805 System and method for coding information on a biosensor test strip |
| 01/27/2005 | US20050019804 Random array of microspheres |
| 01/27/2005 | US20050019801 Stem cell-based methods for identifying and characterizing agents |
| 01/27/2005 | US20050019799 Optical biosensor |
| 01/27/2005 | US20050019791 Amidation; lamination; solid phase synthesis; detecting hybridization; genotyping |
| 01/27/2005 | US20050019790 Fixation of nucleotide derivatives to solid carrier |
| 01/27/2005 | US20050019787 Apparatus and methods for analyzing and characterizing nucleic acid sequences |
| 01/27/2005 | US20050019781 Using concentration of neural cell adhesion molecule as doagnostic indicator of neurodegenerative diseases |
| 01/27/2005 | US20050019778 Sequential generation of multiple chemiluminescent signals on solid supports |
| 01/27/2005 | US20050019775 Separating method and an apparatus performing such a method |
| 01/27/2005 | US20050019773 Method for producing and identifying soluble protein domains |
| 01/27/2005 | US20050019771 Novel germinal center kinase proteins, compositions, and methods of use |
| 01/27/2005 | US20050019770 Macroporous gel, its preparing and its use |
| 01/27/2005 | US20050019768 Hepatocellular carcinoma-related genes and polypeptides, and method for detecting hepatocellular carcinomas |
| 01/27/2005 | US20050019765 Methods for treating disorders of the nervous and reproductive systems |
| 01/27/2005 | US20050019763 Isolated polypeptide of given sequence; expression vectors, host cells, antibodies, agonists, and antagonists; use in diagnosing, treating, or preventing various disorders |
| 01/27/2005 | US20050019756 Methods and compositions for use in diagnosing and characterizing diseases involving abnormal apoptosis |
| 01/27/2005 | US20050019755 Formation of superparamagnetic particles |
| 01/27/2005 | US20050019754 Peptides of given sequence with immunogenic epitopes activating CD8+ class I major histocompatibility complex restricted cytotoxic T-lymphocytes for patients harboring latent HCMV infection in the absence of active viral replication; using enriched antigen presenting cells; vaccines |
| 01/27/2005 | US20050019751 Contacting human scavenger receptor class B type I with polypeptide and measuring ability of test compound to inhibit binding; used in treatment and prophylaxis |
| 01/27/2005 | US20050019746 G-protein coupled receptors (GPCR); determining whether test agent modulates function of protein by detecting signal generated from their interaction; use in identifying compounds that inhibits tumor cell proliferation |
| 01/27/2005 | US20050019745 Coating a support to form a receiving layer with a modifiable elastic modulus, submerge into the intermediate layer, removing fluid medium from the suspension and fixing so the element can withstand wet processing. |
| 01/27/2005 | US20050019742 Measuring the efficacy of anti-platelet therapies at the point of care (without delays) and detecting presence of micro-aggregates; small amount of anticoagulant used |
| 01/27/2005 | US20050019573 comprises biotin covalently attached to a polymer that has monosaccharide or amino acid as a constituent monomer covalently attached to a luminescent substance (cyanoisoindoles, luminols, and acridinium esters); detecting a target substance at high sensitivity |
| 01/27/2005 | US20050019513 Glass capillary tubes for microinjection, and method for manufacturing a microinjection glass capillary tube |
| 01/27/2005 | US20050019454 Eating quality grade |
| 01/27/2005 | US20050019363 Hydrolyzed urea condensate fertilizer, fungicide and insecticide |
| 01/27/2005 | US20050019343 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease |
| 01/27/2005 | US20050019338 Nuclei density and nuclei area methods for determining effects of a botulinum toxin on muscles |
| 01/27/2005 | US20050019330 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta |
| 01/27/2005 | US20050019329 Methods of reducing vascular permeability in tissue by inhibition of tissue plasminogen activator (tPA) and tPA inhibitors useful therein |
| 01/27/2005 | US20050019326 Antiinflammatory agents; tissue injury; autoimmune disease; anticancer agents |
| 01/27/2005 | US20050019322 Treatment of central nervous system diseases by antibodies against glatiramer acetate |
| 01/27/2005 | US20050019320 Controlling food intake; controlling gene expression of G protein; polypeptide |
| 01/27/2005 | US20050019312 Purification of heat shock/stress protein cell surface receptors and their use as immunotherapeutic agents |
| 01/27/2005 | US20050019304 Novel human mage-like protein |
| 01/27/2005 | US20050019263 Conjugate for differentiating between healthy and unhealthy tissue |
| 01/27/2005 | US20050019261 Using serine protease inhibitor; contacting brain tissue; analyzing in variations in protease gene expression |
| 01/27/2005 | US20050019259 Screening methods for pathogen virulence factors under low oxygen conditions |
| 01/27/2005 | US20050019258 Therapy for incontinence; insertion of cooling fluid into bladder of guinea pig in prevence of test drug; measuring reduction of transition point of bladder contraction ; drug screening |
| 01/27/2005 | US20050019255 Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging |
| 01/27/2005 | US20050019251 Administering isotope labeled water to tissue; measurement; calibration |
| 01/27/2005 | US20050019222 Porous substrate and delivery means for laying down particles of a sample of fluid, delivery means comprising an inlet for fluid, and a passageway arranged that it controls flow and spreading of fluid; use in cytological examination screening for cancer of the cervix |
| 01/27/2005 | US20050019219 Temperature detecting analytical device comprising portion for mounting analytical tool such as a biosensor capable of outputting information for computation, computation unit for analyzing sample, and temperature detection unit disposed in mounting portion; use in blood glucose level measuring devices |
| 01/27/2005 | US20050019214 Prepared for use as bindable substances in biological applications by solvating a polymeric microsphere particle with a photographic coupler and a high boiling organic solvent |
| 01/27/2005 | US20050019211 Constructed to include a substrate and a bio-carbon circuit pattern formed of two circuits and printed on the substrate; enables examiner to pick up test sample directly from patient through a direct contact, or through a pipette or the like by dropping |
| 01/27/2005 | US20050019105 Methods in the engineering design and construction of earthen fills |
| 01/27/2005 | US20050018946 Molecular detection using an optical waveguide fixed to a cantilever |
| 01/27/2005 | US20050018945 Optical fiber bragg grating coating removal detection |
| 01/27/2005 | US20050018944 Polarization modulation interrogation of grating-coupled waveguide sensors |
| 01/27/2005 | US20050018887 Analysing spots in a 2-d array |
| 01/27/2005 | US20050018583 Multiple data layer optical discs for detecting analytes |
| 01/27/2005 | US20050018176 Real-time on-line sensing and control of emulsions in formation fluids |
| 01/27/2005 | US20050017738 Temperature compensation method for soot sensor |